Study of type 2 diabetes management among patients in a Macau primary care setting

Family Medicine and Community Health
In Wong

Abstract

In the primary care setting in Macau, type 2 diabetes mellitus (T2DM) is the seventh most common reason for consultation. Inadequate glycaemic control constitutes a major public health problem and is associated with premature death and disability and decreased quality of life. Moreover, this condition substantially increases healthcare expenditures. The primary objective was to assess the successful glycaemic control rates, blood pressure (BP) and cholesterol control rates in patients with T2DM in a Macau primary care setting. The secondary objective of this study was to assess the delay of insulin initiation in the Sao Lourence Health Center. Patients were stratified according to age (<65 years vs ≥65 years) and sex. Successful glycaemic control was defined as glycated haemoglobin (HbA1c) <7%. Successful cholesterol control was defined as a low-density lipoprotein cholesterol (LDL-C) level <2.6 mmol/L, and BP control was defined as BP <140/90 mm Hg. Among the 2157 participants included in this study, 1046 (48.5%) patients had HbA1c <7%, 1209 (56.1%) patients had BP <140/90 mm Hg and 1244 (57.7%) patients had LDL-C <2.6 mmol/L. In conclusion, only 403 (18.7%) patients met the targets for all three measures. Of the 235 patients ...Continue Reading

References

Oct 29, 2000·American Journal of Physiology. Endocrinology and Metabolism·C E GleasonR P Robertson
Jun 29, 2004·Diabetes Care·Jonathan B BrownAndrew Perry
Sep 24, 2004·Annals of Internal Medicine·Elizabeth SelvinSherita Hill Golden
Oct 16, 2004·The Journal of Clinical Endocrinology and Metabolism·Kathrin MaedlerMarc Y Donath
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Dec 1, 2007·Endocrine Reviews·Vincent Poitout, R Paul Robertson
Jun 7, 2008·The Diabetes Educator·Mary E LarkinDavid M Nathan
Aug 8, 2009·Asia-Pacific Journal of Public Health·Charumathi SabanayagamTien Yin Wong
Sep 16, 2009·International Journal of Clinical Practice. Supplement·T Kunt, F J Snoek
May 20, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Rong ChenDajin Zou
Oct 24, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Linong JiSanjiv Bhambani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.